Web Stats Provided By Google Analytics

Tuesday, July 28, 2015

Sanofi and Regeneron Ink $2.2 Billion Immuno-Oncology, PD-1 Inhibitor Deal

July 28, 2015 By Mark Terry , BioSpace.com Breaking News Staff Tarrytown, N.Y.-based Regeneron Pharmaceuticals announced today it had inked a global collaboration agreement with Paris-based Sanofi to develop and market cancer treatments utilizing programmed cell death protein 1 inhibitors. Sanofi is making an upfront payment of $640 million to Regeneron.
http://ift.tt/1IFQLOJ

No comments:

Post a Comment

Popular Tarrytown Roundup Posts